Treatment-resistant depression in the age of serotonin: evolving strategies
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Serotonin specific reuptake inhibitor antidepressants (SSRIs) have become the de facto first line treatment in pharmacotherapy of major depression. Albeit SSRIs have the advantage in tolerance and safety over older treatments, their ease of use does not circumvent the major enduring clinical problem of treatment resistant depression (TRD). For TRD in the setting of an SSRI failure recent data supports a range of strategies including switching, either to a second SSRI or out of the class to a non-SSRI antidepressant, or augmentation with the addition of lithium carbonate. Data concerning use of buspirone and pindolol, serotonin 1A receptor partial agonists, as augmentation agents in SSRI failure remains mixed. In contrast venlafaxine continues to look quite promising in TRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transcranial Magnetic Stimulation: Applications in Neuropsychiatry
George, M. S., Lisanby, S. H., & Sackeim, H. A. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.4.300 · Cited by 496
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399
Thase, M. E. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1002 · Cited by 331
Venlafaxine for Treatment-Resistant Unipolar Depression
NIERENBERG, A. A., FEIGHNER, J. P., RUDOLPH, R., COLE, J. O., & SULLIVAN, J. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199412000-00008 · Cited by 198
Cited by
Handbook of Positive Psychology
(2001) · doi:10.1093/oso/9780195135336.001.0001 · Cited by 9,059
Keyes, C. L. M. (2007) · American Psychologist · doi:10.1037/0003-066x.62.2.95 · Cited by 2,268
Berlim, M. T., & Turecki, G. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200108 · Cited by 412
“However, there is an emerging consensus that TRD is usually best understood not as an all-or-none phenomenon but as one that occurs along a continuum ranging from partial response to complete treatment resistance.(2,10,11)”
BackgroundInfluentialBerlim, M. T., & Turecki, G. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.009 · Cited by 249
Ruhé, H. G., Huyser, J., Swinkels, J. A., & Schene, A. H. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1203 · Cited by 230
Metadata
- Authors
- OʼReardon, J. P., Brunswick, D. J., & Amsterdam, J. D.
- Venue
- Current Opinion in Psychiatry
- Published
- 2000-01
- Volume
- 13
- Issue
- 1
- Pages
- 93-98
- ISSN
- 0951-7367 (ISSN-L)
- OpenAlex
- W2328009081
- Cited by
- 26
- References
- 4
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment-resistant depression in the age of serotonin: evolving strategies. https://app.cochat.ai/papers/10.1097/00001504-200001000-00016
- The paper
- OʼReardon, J. P., Brunswick, D. J., & Amsterdam, J. D. (2000). Treatment-resistant depression in the age of serotonin: evolving strategies. Current Opinion in Psychiatry. https://doi.org/10.1097/00001504-200001000-00016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.